Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Abnormalities, Drug-Induced | 27 | 2024 | 338 | 5.020 |
Why?
|
Limb Deformities, Congenital | 10 | 2022 | 136 | 4.000 |
Why?
|
Anticonvulsants | 29 | 2024 | 1882 | 3.950 |
Why?
|
Polydactyly | 6 | 2023 | 56 | 3.130 |
Why?
|
Congenital Abnormalities | 13 | 2019 | 704 | 3.070 |
Why?
|
Abnormalities, Multiple | 13 | 2022 | 1415 | 2.880 |
Why?
|
Phenytoin | 10 | 2024 | 188 | 2.760 |
Why?
|
Teratogens | 12 | 2021 | 117 | 2.450 |
Why?
|
Fingers | 11 | 2024 | 506 | 2.330 |
Why?
|
Amniotic Band Syndrome | 4 | 2022 | 22 | 2.260 |
Why?
|
Phenobarbital | 8 | 2024 | 189 | 1.850 |
Why?
|
Prenatal Exposure Delayed Effects | 13 | 2024 | 2496 | 1.800 |
Why?
|
Toes | 6 | 2022 | 209 | 1.630 |
Why?
|
Carbamazepine | 7 | 2024 | 224 | 1.550 |
Why?
|
Pregnancy | 73 | 2024 | 29712 | 1.460 |
Why?
|
Hand Deformities, Congenital | 3 | 2022 | 174 | 1.400 |
Why?
|
Registries | 18 | 2023 | 8164 | 1.220 |
Why?
|
Epilepsy | 17 | 2023 | 3270 | 1.220 |
Why?
|
Chorionic Villi Sampling | 4 | 2014 | 35 | 1.090 |
Why?
|
Valproic Acid | 6 | 2023 | 442 | 1.080 |
Why?
|
Fetus | 9 | 2022 | 1860 | 1.030 |
Why?
|
Prenatal Diagnosis | 9 | 2018 | 1264 | 1.030 |
Why?
|
Hypospadias | 2 | 2017 | 97 | 1.010 |
Why?
|
Infant, Newborn | 43 | 2022 | 26176 | 0.980 |
Why?
|
Chromosome Aberrations | 5 | 2018 | 1764 | 0.920 |
Why?
|
Pallister-Hall Syndrome | 1 | 2023 | 4 | 0.900 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2023 | 100 | 0.840 |
Why?
|
Teratology | 2 | 2020 | 8 | 0.830 |
Why?
|
Hypothalamic Diseases | 2 | 2023 | 134 | 0.820 |
Why?
|
Syndactyly | 2 | 2022 | 72 | 0.810 |
Why?
|
Finger Phalanges | 1 | 2022 | 41 | 0.810 |
Why?
|
Maternal Exposure | 8 | 2018 | 1045 | 0.790 |
Why?
|
Anencephaly | 2 | 2018 | 20 | 0.770 |
Why?
|
Hamartoma | 2 | 2023 | 235 | 0.760 |
Why?
|
Hip Dislocation, Congenital | 2 | 2014 | 224 | 0.740 |
Why?
|
Abortion, Spontaneous | 3 | 2023 | 530 | 0.720 |
Why?
|
Pregnancy Complications | 14 | 2022 | 2940 | 0.660 |
Why?
|
Neural Tube Defects | 2 | 2019 | 254 | 0.650 |
Why?
|
Foot Deformities, Congenital | 2 | 2018 | 59 | 0.650 |
Why?
|
Face | 4 | 2021 | 1017 | 0.610 |
Why?
|
Foramen Magnum | 1 | 2018 | 41 | 0.600 |
Why?
|
Double Outlet Right Ventricle | 1 | 2018 | 60 | 0.590 |
Why?
|
Ectromelia | 2 | 2009 | 28 | 0.590 |
Why?
|
Pregnancy in Diabetics | 2 | 2018 | 194 | 0.580 |
Why?
|
Genes, X-Linked | 1 | 2018 | 128 | 0.570 |
Why?
|
Triazines | 3 | 2016 | 310 | 0.550 |
Why?
|
Abortion, Eugenic | 1 | 2016 | 39 | 0.540 |
Why?
|
Triploidy | 1 | 2016 | 3 | 0.540 |
Why?
|
General Adaptation Syndrome | 1 | 2016 | 7 | 0.530 |
Why?
|
Female | 86 | 2024 | 389943 | 0.520 |
Why?
|
Stillbirth | 2 | 2019 | 368 | 0.510 |
Why?
|
Urethra | 1 | 2017 | 402 | 0.490 |
Why?
|
Genes, Recessive | 1 | 2018 | 626 | 0.490 |
Why?
|
Physical Examination | 1 | 2021 | 1245 | 0.480 |
Why?
|
Genes, Dominant | 2 | 2009 | 862 | 0.480 |
Why?
|
Infant | 17 | 2024 | 36045 | 0.470 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1485 | 0.460 |
Why?
|
Anti-Retroviral Agents | 3 | 2019 | 1780 | 0.460 |
Why?
|
Clubfoot | 1 | 2014 | 87 | 0.450 |
Why?
|
Fructose | 2 | 2014 | 288 | 0.450 |
Why?
|
Penis | 1 | 2014 | 212 | 0.450 |
Why?
|
Fetal Growth Retardation | 2 | 2017 | 579 | 0.440 |
Why?
|
Hydatidiform Mole | 1 | 2016 | 254 | 0.440 |
Why?
|
Delayed Diagnosis | 1 | 2017 | 462 | 0.430 |
Why?
|
Neck | 1 | 2018 | 731 | 0.430 |
Why?
|
Anus, Imperforate | 1 | 2013 | 63 | 0.420 |
Why?
|
Birth Weight | 3 | 2017 | 2095 | 0.420 |
Why?
|
Heterocyclic Compounds, 3-Ring | 3 | 2021 | 278 | 0.420 |
Why?
|
Vascular Malformations | 1 | 2018 | 464 | 0.400 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2015 | 491 | 0.400 |
Why?
|
Ectodermal Dysplasia | 1 | 2013 | 106 | 0.400 |
Why?
|
Pubic Bone | 1 | 2011 | 31 | 0.400 |
Why?
|
Humans | 95 | 2024 | 757566 | 0.400 |
Why?
|
Cervical Vertebrae | 1 | 2018 | 977 | 0.380 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2012 | 140 | 0.380 |
Why?
|
Maternal Age | 1 | 2014 | 806 | 0.380 |
Why?
|
Placenta | 2 | 2017 | 1703 | 0.370 |
Why?
|
Pancreatic Diseases | 1 | 2013 | 343 | 0.360 |
Why?
|
Amines | 1 | 2012 | 281 | 0.360 |
Why?
|
Pregnancy Outcome | 8 | 2021 | 2904 | 0.360 |
Why?
|
Misoprostol | 3 | 2020 | 93 | 0.350 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1263 | 0.350 |
Why?
|
Lasers | 1 | 2014 | 951 | 0.340 |
Why?
|
Growth Disorders | 2 | 2013 | 653 | 0.330 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2018 | 1896 | 0.330 |
Why?
|
Nose | 1 | 2013 | 519 | 0.330 |
Why?
|
Encephalocele | 2 | 2018 | 135 | 0.320 |
Why?
|
Bone Regeneration | 1 | 2012 | 432 | 0.320 |
Why?
|
Urogenital Abnormalities | 1 | 2011 | 256 | 0.320 |
Why?
|
Thalidomide | 3 | 2020 | 884 | 0.320 |
Why?
|
Societies, Medical | 1 | 2020 | 3887 | 0.300 |
Why?
|
International Classification of Diseases | 2 | 2021 | 891 | 0.300 |
Why?
|
Hypothyroidism | 1 | 2013 | 665 | 0.300 |
Why?
|
Hand | 3 | 2021 | 902 | 0.300 |
Why?
|
Autistic Disorder | 1 | 2017 | 1216 | 0.290 |
Why?
|
Genes, Homeobox | 1 | 2009 | 284 | 0.290 |
Why?
|
Pelvis | 1 | 2011 | 732 | 0.280 |
Why?
|
Heart Defects, Congenital | 3 | 2021 | 4673 | 0.280 |
Why?
|
Developmental Disabilities | 1 | 2016 | 1504 | 0.280 |
Why?
|
Kidney Diseases | 1 | 2018 | 2082 | 0.280 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1414 | 0.280 |
Why?
|
Facies | 2 | 2005 | 222 | 0.280 |
Why?
|
Mexican Americans | 1 | 2007 | 165 | 0.270 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2013 | 781 | 0.270 |
Why?
|
Mortality | 1 | 2018 | 2882 | 0.270 |
Why?
|
Cleft Palate | 1 | 2012 | 587 | 0.270 |
Why?
|
Child | 14 | 2024 | 79782 | 0.260 |
Why?
|
Vascular Diseases | 1 | 2014 | 1160 | 0.260 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2012 | 1132 | 0.260 |
Why?
|
Tretinoin | 1 | 2009 | 519 | 0.260 |
Why?
|
Pregnancy Trimester, First | 4 | 2017 | 906 | 0.260 |
Why?
|
Virilism | 1 | 2005 | 28 | 0.250 |
Why?
|
Phenotype | 7 | 2021 | 16533 | 0.240 |
Why?
|
HIV Infections | 6 | 2021 | 17270 | 0.240 |
Why?
|
Neurology | 1 | 2013 | 778 | 0.240 |
Why?
|
Metacarpophalangeal Joint | 2 | 2018 | 82 | 0.240 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 2004 | 9 | 0.240 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2005 | 246 | 0.240 |
Why?
|
Hernia, Diaphragmatic | 1 | 2005 | 246 | 0.240 |
Why?
|
Intelligence Tests | 2 | 2022 | 500 | 0.240 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 2005 | 104 | 0.230 |
Why?
|
Gestational Age | 6 | 2021 | 3565 | 0.230 |
Why?
|
Oxazines | 3 | 2021 | 342 | 0.230 |
Why?
|
Duane Retraction Syndrome | 1 | 2004 | 59 | 0.220 |
Why?
|
Hemangioma | 1 | 2009 | 727 | 0.220 |
Why?
|
Preimplantation Diagnosis | 1 | 2005 | 143 | 0.210 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3432 | 0.210 |
Why?
|
Prevalence | 9 | 2019 | 15640 | 0.210 |
Why?
|
Substance Abuse, Intravenous | 1 | 2007 | 529 | 0.210 |
Why?
|
Dermatoglyphics | 1 | 2002 | 20 | 0.210 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2005 | 635 | 0.210 |
Why?
|
Hand Deformities | 1 | 2002 | 16 | 0.210 |
Why?
|
Alcohol Dehydrogenase | 1 | 2002 | 111 | 0.200 |
Why?
|
Neonatal Screening | 2 | 2017 | 594 | 0.200 |
Why?
|
Kidney | 1 | 2018 | 7012 | 0.200 |
Why?
|
Nails | 1 | 2024 | 295 | 0.200 |
Why?
|
Fetal Development | 2 | 2018 | 766 | 0.200 |
Why?
|
Child, Preschool | 9 | 2024 | 42045 | 0.200 |
Why?
|
Boston | 4 | 2018 | 9298 | 0.200 |
Why?
|
Male | 34 | 2024 | 358180 | 0.200 |
Why?
|
Vitamin K | 1 | 2004 | 318 | 0.190 |
Why?
|
Genetics, Medical | 1 | 2024 | 336 | 0.190 |
Why?
|
North America | 2 | 2023 | 1273 | 0.180 |
Why?
|
Pyridones | 3 | 2021 | 785 | 0.180 |
Why?
|
Antifibrinolytic Agents | 1 | 2004 | 292 | 0.180 |
Why?
|
Mesoderm | 1 | 2004 | 672 | 0.180 |
Why?
|
Thumb | 1 | 2002 | 232 | 0.180 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2021 | 2125 | 0.170 |
Why?
|
Autopsy | 1 | 2004 | 1003 | 0.170 |
Why?
|
Craniofacial Abnormalities | 2 | 2017 | 315 | 0.170 |
Why?
|
Ultrasonography | 3 | 2021 | 5951 | 0.170 |
Why?
|
Translocation, Genetic | 1 | 2005 | 1387 | 0.160 |
Why?
|
Cardiovascular Abnormalities | 1 | 2019 | 143 | 0.160 |
Why?
|
Hydranencephaly | 1 | 2018 | 5 | 0.150 |
Why?
|
Poland Syndrome | 1 | 2018 | 14 | 0.150 |
Why?
|
Medical Records | 3 | 2012 | 1406 | 0.150 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3602 | 0.140 |
Why?
|
Massachusetts | 4 | 2017 | 8815 | 0.140 |
Why?
|
Hemoglobinopathies | 1 | 2018 | 96 | 0.140 |
Why?
|
Adult | 28 | 2021 | 219725 | 0.140 |
Why?
|
Metatarsal Bones | 1 | 2018 | 111 | 0.140 |
Why?
|
Benzoxazines | 1 | 2018 | 310 | 0.140 |
Why?
|
Brain Neoplasms | 1 | 2018 | 8981 | 0.140 |
Why?
|
Mice, Inbred C3H | 2 | 2009 | 915 | 0.130 |
Why?
|
Meningomyelocele | 1 | 2018 | 170 | 0.130 |
Why?
|
Obstetric Labor, Premature | 1 | 2017 | 272 | 0.130 |
Why?
|
Consanguinity | 1 | 2018 | 456 | 0.130 |
Why?
|
Piperazines | 3 | 2021 | 2511 | 0.130 |
Why?
|
Ultrasonography, Prenatal | 4 | 2021 | 1744 | 0.130 |
Why?
|
Adenine | 1 | 2021 | 975 | 0.130 |
Why?
|
Cell Hypoxia | 1 | 2018 | 656 | 0.120 |
Why?
|
Chorionic Gonadotropin | 1 | 2017 | 457 | 0.120 |
Why?
|
Zidovudine | 1 | 2017 | 624 | 0.120 |
Why?
|
Pedigree | 2 | 2018 | 4578 | 0.120 |
Why?
|
Incidental Findings | 1 | 2019 | 693 | 0.120 |
Why?
|
Head and Neck Neoplasms | 1 | 2009 | 2881 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 1348 | 0.120 |
Why?
|
Cognition Disorders | 2 | 2007 | 3975 | 0.120 |
Why?
|
United States | 13 | 2022 | 71902 | 0.120 |
Why?
|
Reference Standards | 1 | 2018 | 1003 | 0.110 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2018 | 378 | 0.110 |
Why?
|
Analysis of Variance | 2 | 2016 | 6230 | 0.110 |
Why?
|
Karyotyping | 1 | 2016 | 1171 | 0.110 |
Why?
|
Foot | 1 | 2018 | 573 | 0.110 |
Why?
|
Cohort Studies | 7 | 2014 | 41190 | 0.110 |
Why?
|
Anti-HIV Agents | 2 | 2021 | 4502 | 0.110 |
Why?
|
Canada | 2 | 2011 | 2109 | 0.100 |
Why?
|
SEER Program | 1 | 2018 | 1454 | 0.100 |
Why?
|
Sex Distribution | 1 | 2018 | 2278 | 0.100 |
Why?
|
Risk | 5 | 2017 | 9590 | 0.100 |
Why?
|
Infant, Low Birth Weight | 1 | 2017 | 858 | 0.100 |
Why?
|
Isoxazoles | 1 | 2014 | 230 | 0.100 |
Why?
|
Elbow | 1 | 2012 | 130 | 0.100 |
Why?
|
Cephalometry | 1 | 2013 | 382 | 0.090 |
Why?
|
History, 21st Century | 2 | 2024 | 1568 | 0.090 |
Why?
|
Population Surveillance | 3 | 2019 | 2599 | 0.090 |
Why?
|
Botswana | 3 | 2019 | 1040 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2018 | 1317 | 0.090 |
Why?
|
Heart Failure | 1 | 2015 | 11595 | 0.090 |
Why?
|
Drug Therapy, Combination | 3 | 2021 | 6292 | 0.090 |
Why?
|
Hungary | 1 | 2010 | 82 | 0.090 |
Why?
|
Prenatal Care | 3 | 2012 | 1129 | 0.090 |
Why?
|
Case-Control Studies | 4 | 2014 | 22022 | 0.090 |
Why?
|
Cartilage | 2 | 2012 | 806 | 0.090 |
Why?
|
Central Nervous System Neoplasms | 1 | 2018 | 916 | 0.080 |
Why?
|
Forearm | 1 | 2012 | 427 | 0.080 |
Why?
|
History, 20th Century | 2 | 2024 | 2769 | 0.080 |
Why?
|
Mouth Abnormalities | 1 | 2009 | 19 | 0.080 |
Why?
|
Bone and Bones | 3 | 2012 | 2558 | 0.080 |
Why?
|
Smoking | 2 | 2018 | 9036 | 0.080 |
Why?
|
Bone Development | 1 | 2012 | 472 | 0.080 |
Why?
|
Genotype | 1 | 2002 | 12951 | 0.080 |
Why?
|
Transcription Factors | 2 | 2005 | 12092 | 0.070 |
Why?
|
Adolescent | 7 | 2018 | 87819 | 0.070 |
Why?
|
Tobacco Smoke Pollution | 1 | 2013 | 812 | 0.070 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 487 | 0.070 |
Why?
|
Lip | 1 | 2009 | 197 | 0.070 |
Why?
|
Maternal Health Services | 1 | 2012 | 455 | 0.070 |
Why?
|
Mice, Inbred AKR | 1 | 2006 | 104 | 0.070 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2007 | 310 | 0.070 |
Why?
|
Genetic Diseases, Inborn | 1 | 2011 | 601 | 0.070 |
Why?
|
Texas | 1 | 2007 | 402 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2465 | 0.070 |
Why?
|
Chromosomal Instability | 1 | 2007 | 178 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10749 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1821 | 0.070 |
Why?
|
Mouth | 1 | 2009 | 380 | 0.070 |
Why?
|
Odds Ratio | 2 | 2014 | 9624 | 0.060 |
Why?
|
Amniocentesis | 1 | 2005 | 115 | 0.060 |
Why?
|
Preconception Care | 1 | 2006 | 139 | 0.060 |
Why?
|
Nuchal Translucency Measurement | 1 | 2005 | 59 | 0.060 |
Why?
|
Logistic Models | 4 | 2014 | 13221 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2017 | 79984 | 0.060 |
Why?
|
International Cooperation | 1 | 2011 | 1428 | 0.060 |
Why?
|
Clonazepam | 1 | 2004 | 134 | 0.060 |
Why?
|
Body Patterning | 1 | 2009 | 632 | 0.060 |
Why?
|
Incidence | 2 | 2018 | 21217 | 0.060 |
Why?
|
Religion | 1 | 2007 | 376 | 0.060 |
Why?
|
Reference Values | 1 | 2011 | 4918 | 0.060 |
Why?
|
Twins, Monozygotic | 1 | 2005 | 469 | 0.060 |
Why?
|
Diseases in Twins | 1 | 2005 | 447 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 1888 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2005 | 346 | 0.050 |
Why?
|
Syndrome | 3 | 2007 | 3261 | 0.050 |
Why?
|
Mutation | 2 | 2005 | 29929 | 0.050 |
Why?
|
State Health Plans | 1 | 2005 | 219 | 0.050 |
Why?
|
Ear Canal | 1 | 2004 | 146 | 0.050 |
Why?
|
Facial Asymmetry | 1 | 2004 | 172 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2005 | 500 | 0.050 |
Why?
|
Bone Diseases, Developmental | 1 | 2004 | 131 | 0.050 |
Why?
|
Prospective Studies | 5 | 2019 | 54092 | 0.050 |
Why?
|
Linear Models | 1 | 2013 | 5856 | 0.050 |
Why?
|
Learning | 1 | 2012 | 1738 | 0.050 |
Why?
|
Occipital Bone | 1 | 2002 | 55 | 0.050 |
Why?
|
Cefuroxime | 1 | 2002 | 23 | 0.050 |
Why?
|
Nova Scotia | 1 | 2022 | 34 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2011 | 1658 | 0.050 |
Why?
|
Folic Acid Antagonists | 1 | 2002 | 74 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2014 | 2889 | 0.050 |
Why?
|
Spine | 1 | 2009 | 1111 | 0.050 |
Why?
|
Dioxins | 1 | 2002 | 91 | 0.050 |
Why?
|
National Health Programs | 1 | 2005 | 439 | 0.050 |
Why?
|
Fathers | 1 | 2004 | 376 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2009 | 1533 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2014 | 3726 | 0.050 |
Why?
|
Siblings | 1 | 2005 | 824 | 0.050 |
Why?
|
Age of Onset | 1 | 2008 | 3296 | 0.050 |
Why?
|
Genetic Counseling | 1 | 2005 | 624 | 0.050 |
Why?
|
Perception | 1 | 2007 | 1194 | 0.050 |
Why?
|
Patient Care Planning | 1 | 2006 | 906 | 0.050 |
Why?
|
Alcohol Drinking | 2 | 2004 | 4019 | 0.040 |
Why?
|
Arm | 1 | 2003 | 584 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7796 | 0.040 |
Why?
|
Skull | 1 | 2004 | 815 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2003 | 1567 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2412 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5815 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2009 | 21990 | 0.040 |
Why?
|
Intelligence | 1 | 2004 | 921 | 0.040 |
Why?
|
Abortion, Induced | 1 | 2004 | 459 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2023 | 58558 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2009 | 2638 | 0.040 |
Why?
|
Microcephaly | 1 | 2002 | 425 | 0.040 |
Why?
|
Alanine | 1 | 2021 | 603 | 0.040 |
Why?
|
Risk Factors | 6 | 2013 | 73708 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 23816 | 0.040 |
Why?
|
Heterozygote | 1 | 2005 | 2797 | 0.040 |
Why?
|
Pediatrics | 1 | 2013 | 3586 | 0.040 |
Why?
|
Epidemiologic Methods | 1 | 2002 | 1336 | 0.040 |
Why?
|
Sexual Behavior | 1 | 2007 | 2154 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8502 | 0.040 |
Why?
|
Alkynes | 1 | 2018 | 313 | 0.040 |
Why?
|
Electroencephalography | 1 | 2013 | 6187 | 0.040 |
Why?
|
HIV Integrase Inhibitors | 1 | 2019 | 165 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2006 | 20037 | 0.040 |
Why?
|
Fertilization in Vitro | 1 | 2005 | 1292 | 0.040 |
Why?
|
Observer Variation | 1 | 2003 | 2599 | 0.040 |
Why?
|
Hearing Loss | 1 | 2004 | 781 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2018 | 432 | 0.030 |
Why?
|
Health Surveys | 1 | 2005 | 4056 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 12870 | 0.030 |
Why?
|
Ischemia | 1 | 2003 | 1863 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4577 | 0.030 |
Why?
|
Cognition | 1 | 2012 | 6952 | 0.030 |
Why?
|
Radiography | 2 | 2003 | 6956 | 0.030 |
Why?
|
Infant, Small for Gestational Age | 1 | 2017 | 460 | 0.030 |
Why?
|
Warfarin | 1 | 2002 | 1483 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2002 | 1870 | 0.030 |
Why?
|
Animals | 3 | 2011 | 167718 | 0.030 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2014 | 431 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4407 | 0.020 |
Why?
|
Hospitals | 1 | 2005 | 3861 | 0.020 |
Why?
|
Young Adult | 5 | 2018 | 58755 | 0.020 |
Why?
|
Alleles | 1 | 2002 | 6894 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12047 | 0.020 |
Why?
|
Mice | 2 | 2009 | 81066 | 0.020 |
Why?
|
Infant, Premature | 1 | 2017 | 2094 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2010 | 39020 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9574 | 0.020 |
Why?
|
Chromosome Banding | 1 | 2007 | 260 | 0.020 |
Why?
|
Education | 1 | 2010 | 533 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1886 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2010 | 635 | 0.020 |
Why?
|
Dwarfism | 1 | 2007 | 137 | 0.020 |
Why?
|
World Health Organization | 1 | 2012 | 1312 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2007 | 25924 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2002 | 4404 | 0.020 |
Why?
|
Hypertelorism | 1 | 2005 | 29 | 0.020 |
Why?
|
Epiglottis | 1 | 2005 | 81 | 0.020 |
Why?
|
Isotretinoin | 1 | 2006 | 132 | 0.020 |
Why?
|
Anthropometry | 1 | 2009 | 1347 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 39811 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3413 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2005 | 568 | 0.010 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2005 | 502 | 0.010 |
Why?
|
Epiphyses | 1 | 2002 | 190 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 2006 | 565 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2007 | 2506 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 2003 | 731 | 0.010 |
Why?
|
Radius | 1 | 2003 | 440 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7927 | 0.010 |
Why?
|
Head | 1 | 2002 | 921 | 0.010 |
Why?
|
Skin | 1 | 2003 | 4464 | 0.010 |
Why?
|
DNA | 1 | 2003 | 7200 | 0.010 |
Why?
|
Asthma | 1 | 2006 | 6172 | 0.000 |
Why?
|
Algorithms | 1 | 2003 | 13952 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2003 | 17767 | 0.000 |
Why?
|
Middle Aged | 1 | 2014 | 219192 | 0.000 |
Why?
|